申请人:Icahn School of Medicine at Mount Sinai
公开号:US20150218148A1
公开(公告)日:2015-08-06
Provided are SUMO activators, which can enhance SUMOylation of SERCA2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.
提供了SUMO活化剂,可以增强SERCA2a的SUMO化作用,对于治疗心力衰竭、心血管疾病、癌症、神经退行性疾病、病毒感染、细菌感染、肝脏疾病、炎症和其他疾病非常有用。